High proportion of carbapenemase producing Escherichia coli and Klebsiella pneumoniae among extended spectrum β-lactamase producers in Nigerian hospitals.
Carbapenem-resistant Enterobacterales are a global problem, but little is known about the burden and origin of carbapenem-resistance in Africa. The objectives of this study were to determine the proportion of carbapenem-resistant isolates among ESBL-producing Enterobacterales (ESBL-E), to identify the underlying mechanism of resistance and to assess the population structure of carbapenem-resistant isolates from Nigeria. ESBL-E (n = 175) from infection were collected at four hospitals in Lagos, Nigeria (2016-2018) and were screened for carbapenem-resistance using Vitek 2 automated system. All carbapenem-resistant ESBL-E were screened for blaCMY-2, blaNDM, blaVIM, blaIMP, blaOXA-181 and blaOXA-48. Genotyping of randomly selected samples was done by whole genome sequencing. Isolates comprised Escherichia coli (n = 113, 64.6%) and Klebsiella pneumoniae (n = 62, 35.4%). Of these, 48 (27.4%) were carbapenem-resistant (15 E. coli and 33 K. pneumoniae). Carbapenem-resistant isolates carried blaNDM (n = 30, 62.5%), blaNDM/OXA-181 (n = 10, 20.8%), blaOXA-181 (n = 2, 4.2%) and blaNDM/OXA-48 (n = 1, 2.1%). No carbapenemase was detected in five isolates. They showed a low diversity and were mainly associated with MLST sequence type (ST) 410 E. coli or ST395 and ST147 K. pneumoniae. carbapenem-resistance is frequent among ESBL-E in Nigeria and mainly associated with blaNDM. Genotyping suggest that these clones possibly originated from South-East Asia.